Biodronate 60 mg Injection is a hypocalcemic agent that belongs to the bisphosphonates class. It is mainly used in lowering blood calcium levels and bone metastases/lesions in cancer patients. Besides this, it is also used to treat mild to moderate Paget's disease. Hypercalcemia (increased calcium levels) is a condition in which the calcium level in your blood is elevated due to certain conditions. Paget’s disease is a serious condition of bone that disrupts the replacement of old bone tissue with new bone tissue, resulting in the new bone that is abnormally shaped, weak, and brittle.

Biodronate 60 mg Injection contains Pamidronate as an active ingredient, which belongs to the class of bisphosphonates. It works by inhibiting the osteoclast bone resorption, which causes bone breakdown. When bone is broken down, the calcium in the bone is released into the bloodstream. Thus, it helps retain the normal density of bones and restores bone integrity, bone strength and bone health.

Biodronate 60 mg Injection may cause certain side effects such as injection site reactions, stomach pain, loss of appetite, nausea, vomiting, fever, headache, dizziness, mouth sores, constipation, and cough. Most of these side effects do not require medical attention and gradually resolve over time. However, if these side effects persist for a longer period, please consult your doctor. Biodronate 60 mg Injection is a parenteral preparation. A trained healthcare professional will administer it. Hence, do not self-administer.

Biodronate 60 mg Injection should be avoided if you are allergic to it or any other components present in it. Before receiving Biodronate 60 mg Injection, let your doctor know about all your medical conditions, sensitivities, and medications you are using to rule out any interactions. Biodronate 60 mg Injection should be used under caution if you have/had kidney disease, liver problems, bone disorders, musculoskeletal pain, and high blood pressure. Biodronate 60 mg Injection is not recommended for use in pregnant women due to foetal harm, and whether this medicine can be used for breastfeeding mothers is unknown. Hence, inform your doctor if you are pregnant or are breastfeeding before receiving Biodronate 60 mg Injection. This medicine is not recommended for use in children as safety and efficacy have not been established.

Biodronate 60 mg Injection contains Pamidronate as an active ingredient, which belongs to the class of bisphosphonates. It works by inhibiting the osteoclast bone resorption, which causes bone breakdown. When bone is broken down, the calcium in the bone is released into the bloodstream. Thus, it helps retain the normal density of bones and restores bone integrity, strength, and health.

Biodronate 60 mg Injection should be avoided if you are allergic to it or any other components present in it. Before receiving Biodronate 60 mg Injection, let your doctor know about all your medical conditions, sensitivities, and medication history you are using to rule out any interactions. Biodronate 60 mg Injection should be used under caution if you have/had kidney disease, liver problems, bone disorders, musculoskeletal pain, and high blood pressure. Biodronate 60 mg Injection is not recommended for use in pregnant women due to foetal harm, and whether this medicine can be used for breastfeeding mothers is unknown. Hence, inform your doctor if you are pregnant or are breastfeeding before receiving Biodronate 60 mg Injection. This medicine is not recommended for use in children as safety and efficacy have not been established.

• Your doctor may suggest certain blood tests, like serum calcium, CBC, and kidney function tests, to check for any unpleasant effects.
• Bone density scans are used to check bone mineral density (BMD).
• Clinical monitoring of serum electrolyte concentrations may also be advised.